The European Association of Pharma Biotechnology (EAPB) represents a central network to promote and develop pharmaceutical biotechnology in Europe.
As a non-profit organization EAPB is linking academia, industry and regulatory bodies.
EAPB is dedicated to the advancement of biotechnology in pharmaceutical sciences, specifically as applied to medicinal drugs, processes, technologies, and associated issues.
Its members constitute professionals from biotechnology and pharmaceutical companies, governmental authorities, academia and scientific organisations.
Dissolution of EAPB
At the EAPB General Assembly held on 17 October 2016 in Berlin the members agreed to the dissolution of the Association from 31.12.2016 onwards.
More information can be found here.